Jaka jest cena za Minerva Surgical, Inc. (UTRS)

Cena za Minerva Surgical, Inc. (UTRS) wynosi $0.0001

Jaka jest kapitalizacja rynkowa dla Minerva Surgical, Inc. (UTRS)

Kapitalizacja rynkowa dla Minerva Surgical, Inc. (UTRS) wynosi $888.00

Przychody Minerva Surgical, Inc. (UTRS)

Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.

Rok	Przychody	Zmień
Za mało danych dla podanych dat.

Rok

Przychody

Zmień

Za mało danych dla podanych dat.

Firma	Przychody	Różnica w przychodach	Kraj
GE HealthCare Technologies Inc. GEHC.US	$20.24B	-	US
Pro Medicus Limited PME.AX	$160.46M	-	AU
BrightSpring Health Services, Inc. Common Stock BTSG.US	$14.37B	-	US
Tempus AI, Inc. TEM.US	$1.43B	-	US
Signify Health, Inc. SGFY.US	-	-	US

Firma

Przychody

Różnica w przychodach

Kraj